Recent Posts on This Topic | See All >
Experimental cancer drug tested in Scottsdale shows promiseTags: cancer research, scottdale health care, tgen
[Source: Ken Alltucker, The Aizona republic] - An experimental cancer drug tested at Scottsdale Healthcare appears to shrink tumors in some skin cancer patients without significant side effects, local researchers said.
The experimental drug GDC-0449 showed promise in a phase-one trial, but it must be tested in more advanced trials with a larger group of patients to gauge the drug's effectiveness, they added.
It was used to test patients with advanced basal cell carcinoma, a rare type of skin cancer.
For more information: Experimental cancer drug tested in Scottsdale shows promise
“Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade. Also, discover The State of Bioscience.